Core Viewpoint - Trading in MaxsMaking Inc. has been halted by Nasdaq for additional information requested from the company following a previous trading suspension by the SEC [1][2]. Group 1: Trading Suspension Details - The SEC suspended trading in MaxsMaking Inc. from 04:00 on November 17, 2025, to 23:59 on December 1, 2025 [1]. - The last sale price of MaxsMaking Inc. shares was $13.00 prior to the trading halt [1]. Group 2: Nasdaq's Request - Trading will remain halted until MaxsMaking Inc. fully satisfies Nasdaq's request for additional information [2].

Core Viewpoint - MaxsMaking Inc. is addressing a ten-day trading suspension ordered by the SEC due to potential manipulation of its securities, which is set to expire on December 1, 2025 [1][2]. Company Response and Cooperation - The Company is fully cooperating with the SEC's inquiry and related inquiries from other capital markets regulators, including Nasdaq Regulation [3]. - MaxsMaking has hired Jacob Frenkel from Dickinson Wright PLLC to advise on the trading suspension and ensure compliance with securities laws [5]. Company Operations and Commitment - MaxsMaking emphasizes its commitment to compliance and has not engaged in any improper trading activities or paid for promotions of its securities [4][6]. - The Company is focused on building shareholder value and has a history of successful operations, including a Nasdaq IPO in July 2025 [6]. Company Background - Founded in 2007 and headquartered in Shanghai, MaxsMaking specializes in customized consumer goods, integrating various production and sales processes [7]. - The Company utilizes sustainable materials and proprietary technologies to deliver high-quality products while emphasizing environmental protection [8].

Core Viewpoint - Chinese concept stocks experienced significant gains, with notable increases in share prices for several companies, indicating a positive market sentiment towards these stocks [1]. Group 1: Stock Performance - QH (趣活) saw a remarkable increase of 48.14%, closing at 1.2300 with a rise of 0.3997 and a trading volume of 68.9363 million [1]. - GURE (海湾资源) rose by 37.33%, reaching a price of 3.928, with an increase of 1.068 and a trading volume of 5.05 million [1]. - MAMK (好定多) increased by 30.31%, closing at 13.630, with a rise of 3.170 and a trading volume of 1.531 million [1]. - CGTL (创智环球科技) experienced a gain of 15.76%, closing at 0.6369, with an increase of 0.0867 and a trading volume of 0.2207 million [1]. - JWEL (聚好商城) rose by 14.25%, closing at 1.908, with an increase of 0.238 and a trading volume of 0.879 million [1].

Core Insights - MaxsMaking Inc. celebrated its Nasdaq listing with a bell-ringing ceremony on November 5, 2025, marking its emergence as an innovation-focused manufacturer in the global market [1][2] - The company aims to leverage proprietary technologies and sustainable practices to enhance its competitiveness in the customized consumer goods sector, particularly in small-batch textile customization [2][3] Company Overview - Founded in 2007 and headquartered in Shanghai, MaxsMaking specializes in customized consumer goods, integrating digital production, software development, product design, brand management, online sales, and international trade [3] - The company operates production facilities in Zhejiang and Henan provinces, focusing on delivering high-quality, cost-effective products while emphasizing environmental protection and social responsibility [3] Future Outlook - The CEO of MaxsMaking expressed that the Nasdaq listing serves as a springboard for new opportunities, aiming to strengthen the company's potential and lay a foundation for sustainable growth [2] - With rising global consumer demand for personalized products, MaxsMaking plans to capture new market opportunities through its technology and integrated operations [2]

Group 1 - The top five gaining Chinese concept stocks at the close were: Chang'an Energy up 51.53%, Haodingduo up 28.62%, Kaixin Auto up 27.56%, Huhu Technology up 15.51%, and Zhengkang International up 14.12% [1] - Chang'an Energy (PTLE) had a closing price of 0.2820 with a gain of 51.53%, translating to an increase of 0.0959 and a trading volume of 206 million [1] - Haodingduo (MAMK) closed at 7.100, rising by 28.62%, which is an increase of 1.580 with a trading volume of 4.3489 million [1] Group 2 - Kaixin Auto (KXIN) saw a closing price of 1.620, up 27.56%, reflecting an increase of 0.350 and a trading volume of 17.5516 million [1] - Huhu Technology (HUHU) closed at 7.410, gaining 15.51%, which is an increase of 0.995 with a trading volume of 0.5916 million [1] - Zhengkang International (ZKIN) had a closing price of 2.910, up 14.12%, translating to an increase of 0.360 and a trading volume of 0.3609 million [1]

Core Insights - MaxsMaking Inc. reported a total revenue of $12.40 million for the first half of fiscal year 2025, marking a 27.43% increase from $9.73 million in the same period last year, primarily driven by a 51.89% surge in domestic sales in mainland China [5][7][3] - The company has adopted a volume-first strategy to expand market share, which has temporarily compressed margins but is viewed as a strategic short-term trade-off [4][11] - Research and development spending increased by 53.50% to enhance production technologies and customization capabilities [4][17] Financial Performance - Revenue for the first half of fiscal year 2025 was $12.40 million, up 27.43% from $9.73 million in the previous year [5][7] - Gross profit decreased to $1.34 million, with a gross profit margin of 10.82%, down from 20.36% in the same period last year [7][11] - Net income fell to $0.18 million compared to $0.98 million in the same period last year, with basic and diluted earnings per share at $0.02, down from $0.13 [7][14] Cost Structure - Cost of revenue increased by 42.70% to $11.06 million, primarily due to rising raw material and labor costs [9][11] - Operating expenses rose by 27.01% to $1.17 million, driven by increased general and administrative expenses [12][17] Market Strategy - The company is diversifying into emerging markets in Oceania, South America, and Africa to mitigate challenges in Asia, North America, and Europe [3][4] - MaxsMaking's successful IPO in July 2025 has strengthened its balance sheet, providing additional capital for strategic initiatives [4][17] Recent Developments - The company completed its IPO, raising $6.5 million from the sale of 1,625,000 A shares at $4.00 each [17][24] - Cash at the end of the first half of fiscal year 2025 was $0.19 million, with net cash provided by operating activities at $0.85 million [15][22]

Group 1 - The top five gainers among Chinese concept stocks include Kuke Music with a rise of 263.64%, Meiyantang with 34.69%, Wangsu Technology with 33.89%, Jian Yong Biotechnology with 24.46%, and Haodingduo with 13.47% [1] - Kuke Music's latest price is 0.0500, with a gain of 0.0363 and a trading volume of 1840.56 thousand [1] - Meiyantang's latest price is 19.140, with a gain of 4.930 and a trading volume of 10.7747 million [1] - Wangsu Technology's latest price is 8.770, with a gain of 2.220 and a trading volume of 2.6759 million [1] - Jian Yong Biotechnology's latest price is 50.020, with a gain of 9.830 and a trading volume of 10.2408 million [1] - Haodingduo's latest price is 3.960, with a gain of 0.470 and a trading volume of 10.7239 million [1]

Group 1 - The top five Chinese concept stocks that experienced the largest declines in closing prices are: Wisdom Logistics down 71.18%, Haodingduo down 34.97%, Jiuzixineng down 20.83%, Jian Yong Biotechnology down 17.76%, and Shangao Life Sciences down 15.97% [1] - Wisdom Logistics (SLGB) closed at 3.000 with a decrease of 41.18%, translating to a drop of 2.100, with a trading volume of 36.8617 million [1] - Haodingduo (MAMK) closed at 3.440, down 34.97%, which is a decrease of 1.850, with a trading volume of 36.2105 million [1] - Jiuzixineng (JZXN) closed at 0.2881, down 20.83%, reflecting a decrease of 0.0758, with a trading volume of 39.3645 million [1] - Jian Yong Biotechnology (MENS) closed at 50.000, down 17.76%, which is a drop of 10.800, with a trading volume of 27.0842 million [1] - Shangao Life Sciences (TATA) closed at 1.000, down 15.97%, translating to a decrease of 0.190, with a trading volume of 613.22 thousand [1]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Click Holdings Limited (CLIK) is up 81% at $11.17 [3] - Avidity Biosciences, Inc. (RNA) is up 43% at $70.72 [3] - Dyne Therapeutics, Inc. (DYN) is up 37% at $23.58 [3] - Zenas BioPharma, Inc. (ZBIO) is up 21% at $29.00 [3] - ProPetro Holding Corp. (PUMP) is up 18% at $7.47 [3] - PepGen Inc. (PEPG) is up 17% at $5.35 [3] - Unusual Machines, Inc. (UMAC) is up 15% at $14.85 [3] - Semler Scientific, Inc. (SMLR) is up 14% at $27.32 [3] - ETHZilla Corporation (ETHZ) is up 13% at $20.51 [3] - Relmada Therapeutics, Inc. (RLMD) is up 13% at $2.38 [3] Premarket Losers - Smart Logistics Global Limited (SLGB) is down 37% at $3.21 [4] - MaxsMaking Inc. (MAMK) is down 22% at $4.08 [4] - Prenetics Global Limited (PRE) is down 14% at $14.40 [4] - United States Antimony Corporation (UAMY) is down 14% at $10.22 [4] - NeurAxis, Inc. (NRXS) is down 12% at $3.01 [4] - Obook Holdings Inc. (OWLS) is down 9% at $11.39 [4] - Qualigen Therapeutics, Inc. (QLGN) is down 9% at $3.30 [4] - Critical Metals Corp. (CRML) is down 8% at $13.70 [4] - Neuphoria Therapeutics Inc. (NEUP) is down 8% at $5.73 [4] - Beam Therapeutics Inc. (BEAM) is down 7% at $25.86 [4]

Company Highlights - Wellgistics Health, Inc. (NASDAQ:WGRX) experienced a significant price increase of 168.16%, reaching $1.08, driven by its blockchain initiative in prescription drug tracking [1][5] - MaxsMaking Inc. (NASDAQ:MAMK) saw its stock price rise by 148.70% to $7.43, following a successful IPO that raised $6.5 million, indicating strong investor interest in its innovative textile production [1][5] - Inhibrx Biosciences, Inc. (NASDAQ:INBX) reported a stock price surge of 94.43% to $55.13, likely due to positive developments in its clinical trials for a rare bone cancer treatment [2][5] - Genenta Science S.p.A. (NASDAQ:GNTA) experienced a 92.72% increase in stock price to $6.22, attributed to promising clinical trial results and a strategic partnership with ANEMOCYTE [3] Market Dynamics - The significant price movements across these companies reflect diverse investor interest in sectors such as healthcare, biotechnology, and consumer goods, influenced by clinical trial outcomes, strategic partnerships, and innovative product offerings [4]